Dive into the groundbreaking work of Professor Franka Kalman, a leading figure in analytical chemistry and separation science. From her foundational contributions to HPLC and Capillary Electrophoresis to her innovative solutions for endotoxin detection, discover how her research at HES-SO Valais-Wallis is shaping the future of biopharmaceutical analysis and global health.

Professor Franka Kalman, a distinguished name in analytical chemistry, is revolutionizing separation science and biopharmaceutical analysis. Recognized as a Champion Woman in Science by Technology Networks in 2025, her work at the University of Applied Sciences of Western Switzerland (HES-SO Valais-Wallis) is at the forefront of innovation. This article explores her career, marked by groundbreaking research and a commitment to fostering the next generation of scientists.

A Legacy of Innovation in Separation Science

For over three decades, Professor Kalman has made significant contributions to separation science and (bio)pharmaceutical analysis. Her highly influential basic and applied work in the early days of Capillary Electrophoresis (CE) and Liquid Chromatography has had a lasting impact on modern separation science and pharmaceutical quality control. Her time as a post-doctoral researcher with Professor Csaba Horvath at Yale University cemented her place at the intersection of basic science and industrial applications.

Revolutionizing Endotoxin Testing

Professor Kalman’s current focus at the Institute of Life Sciences of the HES-SO Valais-Wallis involves cutting-edge research in endotoxin characterization and quantification. Her group is developing innovative chemical-based alternatives to outdated biological endotoxin assays, paving the way for less error-prone, more efficient, and ethical solutions. This breakthrough will be commercialized through the HES-SO Valais-Wallis based start-up “Endolab,” scheduled to launch in 2025.